GlaxoSmithKline Scores Parallel Trade Victory

Law360, New York (September 6, 2006, 12:00 AM EDT) -- The Greek antitrust authority has ruled in favor of pharmaceutical giant GlaxoSmithKline in a parallel trade case that spanned six years.

GSK distributed the epilepsy drug Lamictal, the migraine reliever Imigran, and the asthma medication Severant on a quota system, which Greek wholesalers alleged violated antitrust law.

The wholesalers and pharmacists had complained to Greek antitrust officials in late 2000 about Glaxo's restrictions on sales of the three drugs and said Glaxo was refusing to supply certain wholesalers.

The Hellenic Competition Commission ruled that GlaxoSmithKline’s refusal...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.